149 related articles for article (PubMed ID: 16928829)
1. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck B; Bhattacharyya RS; Feldman D; Knox SJ
Mol Cancer Ther; 2006 Aug; 5(8):2078-85. PubMed ID: 16928829
[TBL] [Abstract][Full Text] [Related]
2. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J
Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
4. Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
Gazi MH; Gong A; Donkena KV; Young CY
Clin Chim Acta; 2007 May; 380(1-2):145-50. PubMed ID: 17346688
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
Yuan H; Young CY; Tian Y; Liu Z; Zhang M; Lou H
Mol Cell Biochem; 2010 Jun; 339(1-2):253-62. PubMed ID: 20148354
[TBL] [Abstract][Full Text] [Related]
8. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
9. Response surface methodology optimizes selenium inhibition of prostate cancer PC-3 cell viability.
Whitcomb A; Li X; Lawson J; Christensen M
J Trace Elem Med Biol; 2024 Jul; 84():127414. PubMed ID: 38489924
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.
Dong Y; Zhang H; Gao AC; Marshall JR; Ip C
Mol Cancer Ther; 2005 Jul; 4(7):1047-55. PubMed ID: 16020662
[TBL] [Abstract][Full Text] [Related]
11. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
Zhang H; Wu Y; Malewicz B; Lu J; Li S; Marshall J; Ip C; Dong Y
Cancer; 2006 Dec; 107(12):2942-8. PubMed ID: 17120196
[TBL] [Abstract][Full Text] [Related]
12. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
[TBL] [Abstract][Full Text] [Related]
13. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
14. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
Wang LG; Liu XM; Chiao JW
Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
Cronauer MV; Nessler-Menardi C; Klocker H; Maly K; Hobisch A; Bartsch G; Culig Z
Br J Cancer; 2000 Jan; 82(1):39-45. PubMed ID: 10638964
[TBL] [Abstract][Full Text] [Related]
16. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
[TBL] [Abstract][Full Text] [Related]
17. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells.
Yuan HQ; Kong F; Wang XL; Young CY; Hu XY; Lou HX
Biochem Pharmacol; 2008 Jun; 75(11):2112-21. PubMed ID: 18430409
[TBL] [Abstract][Full Text] [Related]
19. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
Sinha I; Null K; Wolter W; Suckow MA; King T; Pinto JT; Sinha R
Int J Cancer; 2012 Mar; 130(6):1430-9. PubMed ID: 21500193
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
